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ORIGINAL RESEARCH REPORT
Is Healthy Neuroticism Associated with Longevity? 
A Coordinated Integrative Data Analysis
Nicholas A. Turiano*, Eileen K. Graham†, Sara J. Weston‡, Tom Booth§, Fleur Harrison‖, 
Bryan D. James¶, Nathan A. Lewis**, Steven R. Makkar‖, Swantje Mueller††,‡‡, Kristi M. 
Wisniewski§§, Ruixue Zhaoyang‖‖, Avron Spiro¶¶,***, Sherry Willis†††, K. Warner Schaie‡‡‡, 
Richard B. Lipton§§§, Mindy Katz§§§, Martin Sliwinski‖‖, Ian J. Deary‖‖‖, Elizabeth M. 
Zelinski§§, David A. Bennett¶, Perminder S. Sachdev‖, Henry Brodaty‖, Julian N. Trollor‖,‖‖‖, 
David Ames¶¶¶, Margaret J. Wright****, Denis Gerstorf‡‡, Graciela Muniz-Terrera††††, 
Andrea M. Piccinin**, Scott M. Hofer** and Daniel K. Mroczek†,‡‡‡‡
Individual differences in the Big Five personality traits have emerged as predictors of health and longevity. 
Although there are robust protective effects for higher levels of conscientiousness, results are mixed for 
other personality traits. In particular, higher levels of neuroticism have significantly predicted an increased 
risk of mortality, no-risk at all, and even a reduced risk of dying. The current study hypothesizes that one 
potential reason for the discrepancy in these findings for neuroticism is that interactions among neuroticism 
and other key personality traits have largely been ignored. Thus, in the current study we focus on testing 
whether the personality traits neuroticism and conscientiousness interact to predict mortality. Specifically, 
we borrow from recent evidence of “healthy neuroticism” to explore whether higher levels of neuroticism are 
only a risk factor for increased mortality risk when conscientiousness levels are low. We conducted a pre-
registered integrative data analysis using 12 different cohort studies (total N = 44,702). Although a consistent 
pattern emerged of higher levels of conscientiousness predicting a reduced hazard of dying, neuroticism did 
not show a consistent pattern of prediction. Moreover, no study provided statistical evidence of a neuroticism 
by conscientiousness interaction. The current findings do not support the idea that the combination of high 
conscientiousness and high neuroticism can be protective for longevity. Future work is needed to explore 
different protective factors that may buffer the negative effects of higher levels of neuroticism on health, as 
well as other behaviors and outcomes that may support the construct of healthy neuroticism.
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Using the Big Five personality trait taxonomy as 
a psychological phenotype has resulted in the 
identification of risk-chains leading to poorer health and 
shortened life expectancy (Hampson & Friedman, 2008). 
Convincing evidence suggests that trait neuroticism, 
the propensity towards emotional reactivity and high 
anxiety/negative affect, is associated with a myriad 
of unhealthy behaviors, physiological reactions, and 
poorer health outcomes (Lahey, 2009). Importantly, 
some studies suggest that higher levels of neuroticism 
and related facets are predictive of increased mortality 
risk (e.g., Graham et al., 2017b; Mroczek & Spiro III, 
2007; Roberts, Kuncel, Shiner, Caspi, & Goldberg, 2007). 
Interspersed in the literature, however, are findings that 
suggest higher levels of neuroticism are not associated 
with poorer health and in some cases associated 
with more positive behaviors and health outcomes 
– including increased longevity (Korten et al., 1999; 
Weiss & Costa Jr., 2005). The current study sought to 
investigate the question of whether, and under which 
circumstances, higher levels of neuroticism could protect 
health. We hypothesized that “healthy neuroticism” 
or “neurotic vigilance” (Friedman, 2000) would be 
represented by a trait interaction of neuroticism and 
conscientiousness. Specifically, the combination of high 
neuroticism and high conscientiousness would result 
in reduced mortality risk whereas the combination of 
high neuroticism and low conscientiousness will be 
associated with increased mortality risk. We tested this 
hypothesis in a coordinated analysis framework across 
12 diverse longitudinal studies, some of which span the 
full adult life span.
Personality and Mortality Risk
Among the Big Five personality traits, both 
conscientiousness and neuroticism have received the 
most empirical support in terms of their predictive power 
for longevity. Consistent across countries, health states, 
and ages, strong evidence exists that individuals scoring 
higher in conscientiousness (e.g., propensity to be goal-
directed, responsible, in control of impulses) are more 
likely to be healthier and live longer lives, which has been 
confirmed via meta-analysis (Jokela et al., 2013; Kern & 
Friedman, 2008). On the other hand, individuals scoring 
higher in measures of neuroticism are characterized as 
moody, anxious, emotionally reactive, and impulsive. 
Higher neuroticism is associated with increased alcohol 
consumption (Grekin, Sher, & Wood, 2006; Malouff, 
Thorsteinsson, Rooke, & Schutte, 2007), tobacco use 
(Graham et al., 2017a; Malouff, Thorsteinsson, & Schutte, 
2006), and drug use (Kashdan, Vetter, & Collins, 2005; 
Krueger, Caspi, Moffitt, Silva, & McGee, 1996). Use of these 
substances helps individuals cope with or self-medicate 
the chronically high levels of anxiety and negative 
emotion (Cooper, Agocha, & Sheldon, 2000; Cooper, 
Frone, Russell, & Mudar, 1995). Moreover, those scoring 
higher in neuroticism expose themselves to more stressful 
situations, to which they often react with distress emotions 
like anger (Bolger & Schilling, 2006; Bolger & Zuckerman, 
1995; Magnus, Diener, Fujita, & Pavot, 1993). Thus, 
individuals scoring higher in neuroticism consistently 
expose themselves to heightened cardiovascular reactivity 
and dysregulation of the hypothalamic-pituitary adrenal 
(HPA) axis over their lifespan (Portella, Harmer, Flint, 
Cowen, & Goodwin, 2005; Vedhara, Miles, Sanderman, & 
Ranchor, 2006; Zobel et al., 2004).
The combination of substance abuse, chronic stress, 
and altered cardiovascular function over a lifetime 
can be detrimental to health and ultimately lead to 
premature mortality. Ample studies report an association 
between higher neuroticism and an increased risk of 
all-cause mortality (Batty, Jokela, Kivimaki, & Shipley, 
2016; Chapman, Fiscella, Kawachi, & Duberstein, 2009; 
Christensen et al., 2002; Denollet, Sys, & Brutsaert, 1995; 
Mroczek, Spiro III, & Turiano, 2009; Murberg, Bru, & 
Aarsland, 2001; Ploubidis & Grundy, 2009; Read, Vogler, 
Pedersen, & Johansson, 2006; Shipley, Weiss, Der, Taylor, 
& Deary, 2007; Terracciano, Löckenhoff, Zonderman, 
Ferrucci, & Costa Jr., 2008; Weiss, Gale, Batty, & Deary, 
2009; Wilson, Bienias, Mendes de Leon, Evans, & Bennett, 
2003; Wilson et al., 2005; Wilson, Mendes de Leon, Bienias, 
Evans, & Bennett, 2004). Higher levels of neuroticism have 
also been found to predict cause-specific cardiovascular-
related mortality (Hagger-Johnson et al., 2012; Jokela, 
Pulkki-Råback, Elovainio, & Kivimäki, 2013; Murberg et 
al., 2001; Shipley et al., 2007). Still, several studies (not 
to mention studies never published) have reported no 
associations between neuroticism and mortality risk 
(Almada, Zonderman, & Shekelle, 1991; Friedman et al., 
1995; Huppert & Whittington, 1995; Iwasa et al., 2008; 
Maier & Smith, 1999; Turiano, Chapman, Gruenewald, & 
Mroczek, 2015).
Neuroticism might not always increase mortality 
risk. Some studies provide strong evidence (e.g., large 
statistically significant hazard ratios) that higher 
neuroticism is associated with a reduced risk of dying 
(Korten et al., 1999; Weiss & Costa Jr., 2005). These 
samples largely differed from others as participants were 
older adults (65+) however, findings remained statistically 
significant after adjusting for age. Korten et al. (1999) 
suggested that those with higher levels of neuroticism 
might be more likely to seek medical help for problems, 
whereas individuals scoring low in neuroticism might not. 
Ploubodis and Grundy (2009) found neuroticism was a risk 
factor for increased mortality in men, but protective among 
women. Others have documented that when high levels 
of neuroticism were analyzed in conjunction with either 
higher socioeconomic status (Hagger-Johnson et al., 2012) 
or higher cognitive ability (Weiss et al., 2009), neuroticism 
was no longer a risk factor for increased mortality.
Meta-analytic findings suggest that higher neuroticism 
is either associated with increased mortality risk or 
there is no overall effect. Roberts and colleagues (2007) 
averaged the relative risk ratios of neuroticism from twelve 
studies and found that higher levels of neuroticism were 
indeed a risk factor for mortality. A more recent analysis 
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from seven international samples (n = 76,000+) found 
higher neuroticism was associated with an increased 
risk of death in 3 studies (Health and Retirement Study, 
Midlife in the United States Study, and German Socio-
Economic Panel Study) but null effects for the other four 
(Jokela et al., 2013). The overall meta-analytic effect was 
not significant for neuroticism across studies, but there 
was some evidence that very high levels of neuroticism 
were a risk factor for mortality. Graham and colleagues 
(2017b) explored neuroticism-mortality associations in 
15 longitudinal datasets and identified five studies in 
which higher neuroticism was associated with increased 
mortality risk (Health and Retirement Study, Religious 
Orders Study, Seattle Longitudinal Study, MRC National 
Survey of Health & Development, and Longitudinal Aging 
Study Amsterdam). Within these meta-analyses, no single 
study nor the aggregate meta-analytic effect found higher 
neuroticism as protective. However, higher neuroticism was 
not a universal risk factor for mortality as many individual 
studies found null effects. These two recent meta-analyses 
(Graham et al., 2017b; Jokela et al., 2013) include many of 
the same studies used in the current analysis. However, the 
current analysis utilizes updated data that includes many 
more deaths. Thus, it is key to determine whether findings 
remain consistent with this updated mortality information 
and whether the neuroticism by conscientiousness 
interaction emerges as a significant predictor of mortality 
risk across multiple studies.
Healthy Neuroticism
Although neuroticism is associated with a host of 
unhealthy behavioral choices and suboptimal health 
outcomes (Lahey, 2009), evidence suggests that higher 
neuroticism could be health-beneficial because anxiety 
drives individuals to be more vigilant of somatic symptoms 
(Costa Jr. & McCrae, 1987) as well as utilize health-care 
services (Have, Oldehinkel, Vollebergh, & Ormel, 2005). 
Can neuroticism be protective in some circumstances? 
Friedman (2000) introduced the idea of “healthy 
neuroticism” as a way to explain why high neuroticism 
might actually have some health benefits. He suggested 
that the typical life path of someone scoring high in 
neuroticism would be characterized by pessimism, anger 
and anxiety that ultimately leads to substance abuse, lack 
of preventative health care, chronic negative affect, and 
suboptimal physiological reaction patterns. Alternatively, 
a quite different path would be anxiety that drives more 
proactive health behaviors due to the concern of current 
and future health problems. Thus, a “healthy neurotic” 
is more likely to engage in exercise, healthy eating, and 
preventative health care to alleviate any anxiety about 
poor health or early death.
There is now empirical evidence that high levels of 
conscientiousness may buffer the negative behavioral 
effects of high neuroticism. Vollrath and Torgersen (2002), 
for example, examined personality typologies based on 
levels of neuroticism and conscientiousness (among 
other trait combinations) in relation to substance abuse 
behaviors. They found that individuals scoring lower in 
conscientiousness or higher in neuroticism were more 
likely to smoke, drink, or use drugs. However, when both 
conscientiousness and neuroticism were high, there was 
a decrease in substance use. Likewise, Terracciano and 
Costa (2004) explored neuroticism by conscientiousness 
interactions and found that adults scoring high in 
both conscientiousness and neuroticism were three 
times less likely to smoke cigarettes than those low in 
conscientiousness but high in neuroticism. Thus, higher 
neuroticism was particularly associated with increased 
smoking when conscientiousness was low. Further, 
Weston & Jackson (2015) found that after the onset of 
a major chronic disease, higher levels of neuroticism 
predicted less smoking when conscientiousness levels 
were also high. Lastly, higher levels of conscientiousness 
buffered the negative effects of high neuroticism in 
terms of reduced alcohol consumption and related 
problems (Turiano, Whiteman, Hampson, Roberts, & 
Mroczek, 2012). The aforementioned studies suggest that 
when conscientiousness levels are high, the predictive 
effects of high neuroticism for substance abuse behavior 
are attenuated.
When exploring mortality risk, two studies found 
evidence for healthy neuroticism in regards to mortality 
risk. Friedman and colleagues (2010a) used archival 
data on over 1,000 participants from the Terman study, 
finding that higher neuroticism was protective for men 
but a risk factor for women. More importantly, they 
found a significant neuroticism by conscientiousness 
interaction for women. The plotted survival curves 
showed that women high in conscientiousness and low 
in neuroticism had the lowest mortality risk, but based on 
visual inspection we suggest that there was also a survival 
advantage when neuroticism was high in combination 
with high conscientiousness. As the authors suggested, 
higher neuroticism may become beneficial at certain life 
stages when challenges arise and appropriate actions need 
to be taken. Lastly, in a large meta-analysis of personality-
mortality associations, trait interactions were explored, 
but no consistent pattern emerged across the studies 
and thus data were not presented in the article (Jokela et 
al., 2013). A second study examined over 300,000 adults 
from the UK Biobank study (Gale et al., 2017) and found 
that higher levels of neuroticism predicted a reduced 
mortality risk among those rating their health as fair or 
poor. Although participants did not engage in healthier 
behaviors, they may have been more motivated to seek 
out health-care services for ailments. However, no such 
data were available to test this hypothesis.
The Current Study
The current study is the third in a series of three studies 
submitted to this issue. These studies were the result of a 
single, coordinated project involving multiple co-principal 
investigators and spanning research labs around the 
world. The goal of this project was to rigorously analyze 
evidence for “healthy neuroticism,” narrowly defined 
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as the significant moderation of the neuroticism-
health relationship by conscientiousness. This analysis 
considered multiple components of health, specifically 
behaviors, development of chronic conditions, and 
mortality, following a lifespan trajectory. Despite the 
coordination and similarity of analyses among these three 
components of health, there were notable differences 
between the studies, including the datasets which could 
be used in the analysis, the quantitative models applied, 
and the theoretical rationale linking personality to health. 
Moreover, synthesizing this project in a single manuscript 
would have required over-simplification of critical details 
and decision points along the way. As a result, the three 
components were divided into three separate but linked 
manuscripts, allowing for the requisite detail to be 
included in each. Information on each study in this series 
can be found here.
This specific paper addressed two major gaps in the 
literature. First, we assessed whether higher levels 
of neuroticism were associated with an increased or 
decreased mortality risk in a diverse set of 12 longitudinal 
samples. Second, we tested the trait interaction between 
neuroticism and conscientiousness as a predictor of 
mortality. This examination allowed us to directly assess 
healthy neuroticism – whether high neuroticism was 
only associated with increased mortality risk when 
conscientiousness levels were low. In other words, do 
higher levels of conscientiousness lead to reduced 
mortality risk among highly neurotic individuals? 
The use of a dozen high quality longitudinal datasets 
addressed the uncertainty inherent in any single study 
investigating the neuroticism-mortality association. Our 
pre-registered hypothesis was that the relationship between 
neuroticism and mortality risk would vary as a function 
of conscientiousness level. Moreover, we updated our 
pre-registration just prior to running our analyses to 
explore whether a three-way interaction, represented by 
gender by neuroticism by conscientiousness, predicted 
mortality risk because prior work found that higher 
neuroticism could be protective in women (Ploubidis & 
Grundy, 2009), especially when conscientiousness levels 
are high (Friedman, Kern, & Reynolds, 2010b). Specifically, 
we hypothesized that higher levels of conscientiousness 
would more strongly buffer the negative effects of 
neuroticism on increased mortality risk.
Methods
Coordinated Analysis
Coordinated analysis is a form of integrative data 
analysis that compares optimally similar models 
across multiple studies (Graham et al., 2017b; Hofer 
& Piccinin, 2009). Since the methods used in reports 
from individual longitudinal studies are rarely identical, 
direct comparisons of published results are generally not 
possible. For example, the questions and response formats 
used to assess certain constructs often vary across studies. 
As such, coordinated analyses are conceptual replications: 
instead of harmonizing across measures, coordinated 
analysis uses harmonized models thereby allowing the 
exact measurement of a given construct measurement 
to vary. This approach lends itself to the assessment of 
generalizability and can add to the credibility of results. 
Variation among study characteristics has long been 
considered a constraint on the generality of findings in 
longitudinal research. In coordinated analysis, these 
differences can be a strength: instead of regarding these 
study-level characteristics (e.g. cohort, measurement 
scale, country) as sources of error, researchers may have 
the option to test these differences systematically as 
sources of heterogeneity. By harmonizing the models 
themselves, investigators are able to rule out model 
variations as a source of heterogeneity, and focus on 
study-level characteristics instead. Furthermore, if there 
is consistency in the direction and strength of effect 
in heterogeneous samples, then this is evidence for 
generalizability of the results.
Table 1.
Study Country N Year Age Range Personality Scale Follow-up (Years) N (% Dead)
EAS U.S. 474 2005 69–94 IPIP-50 11.08 128 (22.30)
HRS U.S. 19,211 2006 25–105 MIDI 9.13 3,066 (15.96)
LBC1936 U.K. 962 2006 67–71 IPIP 14.23 218 (22.66)
LBLS U.S. 898 1994 30–97 NEO-PI-R 19.00 131 (14.59)
MAP U.S. 653 2004 56–97 NEO-FFI 13.89 268 (41.04)
MAS Australia 879 2005 70–91 NEO-PI-R 8.42 180 (20.48)
MIDUS U.S. 6,245 1994 20–75 MIDI 21.12 1,069 (17.12)
NAS U.S. 992 1990 47–85 Goldberg 26.90 659 (66.43)
OATS Australia 534 2007 65–90 NEO-PI-R 9.57 56 (10.49)
ROS U.S. 1,394 1994 55–102 NEO-FFI 24.00 792 (56.81)
SLS U.S. 1,649 2001 26–101 NEO-PI-R 16.19 444 (26.93)
WLS U.S. 10,711 1993 33–75 BFI 22.33 1,777 (16.59)
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Sample Information
We included studies affiliated with the Integrative Analysis 
of Longitudinal Studies of Aging and Dementia (IALSA) 
network that had the requisite data to test our hypotheses. 
Within the network, IALSA has established data sharing 
agreements with affiliates that have non-public data. For 
this project, studies with non-public data provided an 
analyst who analyzed the data from their specific study 
for the purpose of evaluating replicability of results. In 
total, 12 longitudinal studies (total N = 44,702; deceased 
N = 8,788) had appropriate data to address the questions 
in the current project. All models used listwise deletion. 
Sample sizes for each model in each dataset are presented 
in Table 1. Ethical approval was obtained at each of the 
primary research sites for each study.
The Einstein Aging Study (EAS) is an observational 
longitudinal cohort study to examine cognitive aging and 
dementia, which began in 1993. Older adults who were 
at least 70 years of age, non-institutionalized, and native 
English speakers were systematically recruited from an 
urban, multi-ethnic, community-dwelling population 
in Bronx County, New York, USA. Participants receive 
comprehensive annual medical and neuropsychological 
evaluations (Katz et al., 2012). For the current project, 
baseline was defined as the first time at which participants 
had completed the personality scales, which ranged 
from 2005 to 2016. Mortality information through was 
obtained via follow-up phone calls and searches within 
the Social Security Death Index. A total of 574 (Mage = 
78.98, SDage = 5.21, 59% female) participants completed 
the baseline personality measure and had mortality 
information available. A total of 128 individuals died 
over the 11.08 year follow-up (Msurvival = 51.15 months, 
SDsurvival = 29.39 months, range = 2–122 months).
The Health and Retirement Study (HRS) is a 
longitudinal panel study that tracks retirement-age 
adults in the United States. Data collection began in 
1992, with new cohorts added throughout the 1990s 
and 2000s (Sonnega et al., 2014). Baseline was defined 
as the first time participants completed the personality 
scales (ranging from 2006 to 2014). Mortality information 
through 2014 was assessed through two methods. First, 
surviving panel members and family members were 
sought to obtain interviews. Second, a search was made 
through the National Death Index to confirm deaths. A 
total of 19,211 (Mage = 66.26, SDage = 11.16, 59% female) 
participants completed personality measures and had 
mortality information available. Of these, 3,066 individuals 
died over the 9.13 year follow-up (Msurvival = 45.11 months, 
SDsurvival = 25.90 months, range = 1–105 months).
The Lothian Birth Cohort 1936 (LBC1936) consists of 
surviving individuals who completed the Scottish Mental 
Health Survey in 1947 (Deary, Gow, Pattie, & Starr, 2012; 
Taylor, Pattie, & Deary, 2018). The LBC 1936 (birth) cohort 
was recruited between 2004 and 2007 by identifying 
individuals from the original 1947 (test) cohort who 
were residing in Edinburgh and the surrounding area. In 
total, 1,091 participants entered the study. Baseline was 
defined as 2006, the first wave of personality assessment 
for all participants. Mortality information was obtained by 
flagging at the National Records of Scotland who provided 
data on the date and cause of each death in the cohort. 
A total of 962 (Mage = 69.50, SDage = 0.84, 51% female) 
participants completed personality measures and had 
mortality information available. Of these, 218 individuals 
died over the 14.23 year follow-up (Msurvival = 90.59 months, 
SDsurvival = 40.03 months, range = 2–161 months).
The Long Beach Longitudinal Study (LBLS) started 
in 1978 and was composed of 589 adults aged 28–84 
years old in southern California who participated in a 
study comparing alternate forms of the Schaie-Thurstone 
Adult Mental Ability tests as well as other psychometric 
measures (Zelinski & Kennison, 2001). A new cohort of 
participants was added and personality was assessed 
using the Revised NEO Personality Inventory (NEO-PI-R; 
(Costa & McCrae, 1992)) in 1994/1995 and 2000/2001. 
Of these, 898 (Mage = 64.81, SDage = 13.19, 56% female) 
participants completed personality assessments and had 
mortality information available. Mortality information 
through 2013 was attained through the National Death 
Index. A total of 131 individuals died over the 19.00 
year follow-up (Msurvival = 113.40 months, SDsurvival = 41.15 
months, range = 12–204 months).
The Rush Memory and Aging Project (MAP) is a 
longitudinal, epidemiologic clinical-pathologic cohort 
study of common chronic conditions of aging with 
emphasis on decline in cognitive and motor function and 
risk of dementia (Bennett et al., 2018; Bennett, Schneider, 
Arvanitakis, & Wilson, 2012). Participants are older adults 
recruited from retirement communities and subsidized 
senior housing facilities throughout the Chicago 
metropolitan area and northern Illinois. Enrollment began 
in 1997 and clinical evaluations and cognitive assessments 
occur annually. Neuroticism was first collected in 1997 
while conscientiousness and extraversion were first 
collected in 2004. Openness and agreeableness were not 
collected. Because MAP is an autopsy study, the exact date 
of death is known for most participants as it is the day an 
autopsy was performed. In addition to annual evaluations, 
participants are also contacted quarterly to determine vital 
status and changes in health, and death is occasionally 
learned of and documented during quarterly contacts. 
Mortality information in the current study included 
deaths up to 2017. Of these, 653 (Mage = 79.69, SDage = 
7.13, 75% female) participants completed personality 
measures and had mortality information available. Of 
these, 268 individuals died over the 13.89 year follow-up 
(Msurvival = 95.99 months, SDsurvival = 31.43 months, range = 
15–161 months).
The Sydney Memory and Ageing Study (MAS) is an 
ongoing longitudinal cohort study of brain aging and 
dementia in older individuals, who undertake medical, 
neuropsychological and psychosocial assessments 
biennially. Individuals without dementia aged 70–90 
and living in the Australian community at baseline 
(between 2005–2007) were randomly recruited through 
the electoral roll (Sachdev et al., 2010). Mortality 
information through 2014 was obtained through the 
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Australian Death Index. A total of 879 (Mage = 78.71, SDage 
= 4.78, 46% female) participants completed personality 
assessments and had mortality information available. Of 
these, 180 individuals died over the 8.42 year follow-up 
(Msurvival = 52.84 months, SDsurvival = 24.91 months, 
range = 4–096 months).
The Midlife in the United States (MIDUS) tudy is an 
ongoing national study of 7,108 participants in the United 
States who were recruited in 1994/1995 and completed 
followed up assessments in 2004/2005 and 2013/2014 
(Brim, Ryff, & Kessler, 2004). Mortality information 
through October 2015 was obtained by three methods. 
First, National Death Index updates were conducted in 
2006 and 2009. Second, deaths were recorded during 
the tracing/closeout phases after fielding the MIDUS 2 
(2005–06) and MIDUS 3 (2013–15) questionnaires. Lastly, 
deaths were recorded during primary data collection. A 
total of 6,245 (Mage = 46.84, SDage = 12.91, 53% female) 
participants completed personality measures at baseline 
(1995–96) and had mortality information available. Of 
these, 1,069 individuals died over the 21.12 year follow-up 
(Msurvival = 135.32 months, SDsurvival = 64.20 months, range 
= 1–245 months).
The Veteran Affairs Normative Aging Study (NAS) is 
a study of the medical and psychosocial aging among men 
in the United States, and is funded by the United States 
Department of Veterans Affairs. The sample is based in 
the Greater Boston, Massachusetts metropolitan area and 
consists of 2,280 men who were enrolled between 1961 
and 1970. The participants were on average 42 years old at 
enrollment (Bossé, Ekerdt, & Silbert, 1984). Personality was 
assessed beginning in 1990. A total of 992 (Mage = 64.57, 
SDage = 7.46) men completed personality measures and had 
mortality information available. Mortality information 
is monitored by periodic mailings to participants and 
notification from next-of-kin or postal authorities. Records 
from the Department of Veterans Affairs and the Social 
Security Administration (Death Master File) are routinely 
reviewed for possible unreported deaths. When deaths 
were reported, a death certificate was obtained and coded 
for the cause of death. For the current project, mortality 
information was most recently updated in 2016. Of the 
992 individuals with personality data, 659 individuals died 
over the 26.90 year follow-up 659 individuals have died 
over the 26.90 year follow-up (Msurvival = 186.95 months, 
SDsurvival = 72.98 months, range = 22–313 months).
The Older Australian Twins Study (OATS) is a multi-
site, longitudinal study of monozygotic and dizygotic 
twins at least 65 years of age, including 623 participants 
who completed baseline assessments (Sachdev et al., 
2009). Personality was measured at study onset (2007) 
using the Revised NEO Personality Inventory (NEO-
PI-R; (Costa & McCrae, 1992)). Mortality information 
through 2014 was obtained from a number of sources 
(e.g., online indexes of deaths appearing in Australian 
newspapers, reports from family members), which were 
confirmed using the National Death Index. A total of 
534 (Mage = 71.40, SDage = 5.55, 65% female) participants 
completed personality assessments and had mortality 
information available. Of these, 56 individuals died over 
the 9.57 year follow-up (Msurvival = 63.76 months, SDsurvival = 
28.53 months, range = 4–115 months).
The Religious Orders Study (ROS) is a longitudinal, 
epidemiologic clinical-pathologic cohort study of aging 
and Alzheimer’s Disease that enrolled older Catholic nuns, 
priests, and brothers from more than 40 groups across 
the United States in 1994 (Bennett et al., 2018, 2012). 
Participants do not have known dementia at baseline and 
agree to annual clinical evaluations, cognitive testing, 
and brain and other tissue donation after death. The NEO 
personality assessment was collected in 1994. A total of 
1,394 (Mage = 75.95, SDage = 7.47, 71% female) participants 
completed personality assessments and had mortality 
information available through 2017. Since ROS is an 
autopsy study, the exact date of death is known for most 
participants as it is the day that an autopsy was performed. 
In addition to contact for annual evaluations, participants 
are contacted quarterly to determine vital status and 
changes in health, and death is occasionally discovered 
during quarterly contacts and documented. Of the total 
1,394 participants with personality data, 792 individuals 
died over the 24.00 year follow-up (Msurvival = 120.75 
months, SDsurvival = 70.73 months, range = 1–288 months).
The Seattle Longitudinal Study (SLS) started in 1956 
and has since collected data on close to 6,000 participants 
in a cohort-sequential design (Schaie, Willis, & Caskie, 
2004). Participants were sampled randomly from members 
of a large health maintenance organization in the Seattle, 
Washington area. A total of 1,656 participants aged 26 
to 101 completed at least one personality assessment 
between 2001 and 2012. Personality was assessed with the 
revised NEO Personality Inventory (Costa & McCrae, 1992). 
A total of 1,649 (Mage = 64.75, SDage = 15.77, 55% female) 
participants completed personality assessments and had 
mortality information available. Mortality information 
through May 2017 was obtained through obituaries, family 
notifications, the Social Security Death Index (only current 
up to 2014), and websites such as Ancestry.com. Of the 
1,649 individuals with personality data, 444 individuals 
died over the 16.19 year follow-up (Msurvival = 64.47 months, 
SDsurvival = 46.14 months, range = 2–190 months).
The Wisconsin Longitudinal Study (WLS) follows 
a cohort of men and women who graduated from 
Wisconsin high schools in 1957. Data from 10,317 
participants span almost 60 years from the baseline 
assessment in 1957, with follow-up assessments 
collected in 1967, 1975, 1993, 2004, and most recently 
in 2011. In addition to the original cohort, subsequent 
assessments included randomly selected siblings and 
spouses of graduate participants (Herd, Carr, & Roan, 
2014). Personality measures were first introduced in the 
WLS in 1993, which served as the baseline assessment 
for the present analyses. A total of 10,681 (Mage = 53.76, 
SDage = 4.52, 54% female) participants completed 
personality assessments and had mortality information 
available. Mortality information through November 2014 
was linked with records from the US National Death 
Index. Of these, 1,777 individuals died over the 22.33 
year follow-up (Msurvival = 160.42 months, SDsurvival = 65.05 
months, range = 3–264 months).
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Materials
The details of each measure, including item text and 
response choices, are described in Supplementary 
File 1, and descriptive statistics for each variable used are 
available here.
Vital Data
Information on how death was recorded within each 
study is described above. Those confirmed as dead by 
the end of the follow-up period (e.g., censor date) were 
coded as 1 and those still alive were coded as 0. We used 
two different time metrics to quantify survival time to 
ensure the robustness of effects. For the primary analysis, 
we created a continuous survival time variable based on 
the interval (in months) from the date when personality 
was first assessed to the date of the participant’s death. 
Participants who were still alive (censored observations) 
had survival times that equaled the length of the 
maximum follow-up for that specific study (e.g., the last 
date a mortality update was provided). As a secondary 
analysis we used the participants’ ages when they first 
completed the personality measures as the starting point 
and age at death (or censor date if they were still alive at 
the end of the follow-up) as the ending point. This analysis 
would test whether effects differed depending on the time 
metric utilized.
Personality
Each of the 12 samples had a baseline assessment of 
the Big Five personality dimensions. All but two studies 
assessed all of the Big Five traits. Notably, the MAP did not 
assess agreeableness or openness, and the MAS did not 
assess agreeableness or extraversion. The most commonly 
used measures were from the NEO family of instruments 
(Costa Jr. & McCrae, 2008). The NEO-PI-R was used in the 
MAS, OATS, and LBLS, while the NEO-FFI was used in the 
ROS and MAP. Two studies used the MIDI ((Lachman & 
Weaver, 1997); HRS, MIDUS), one used the IPIP50 (LBC); 
three used the IPIP adjectives ((Goldberg, 1992; Saucier, 
1994); EAS, LBC, NAS), and one used the BFI ((John & 
Srivastava, 1999); WLS). Cronbach’s alpha coefficients 
were calculated from the samples of participants who 
were eligible for analysis. Internal reliability estimates 
for neuroticism ranged from 0.71 (HRS) to 0.93 (SLS). 
Internal reliability estimates for conscientiousness ranged 
from 0.56 (MIDUS) to 0.90 (SLS). Since the Big Five traits 
are broad constructs, there is variation across different 
measures in terms of the underlying facets/item used 
in a specific scale (John, Naumann, & Soto, 2008). Thus, 
the different measures used in the current analysis are 
beneficial because they capture slightly different ranges 
of meaning for both neuroticism and conscientiousness. 
For example, the IPIP-50 measure of conscientiousness 
included items assessing responsibility, practicality, 
and thriftiness, but not self-discipline or efficiency; in 
contrast, the BFI measures competency and achievement 
but not goal-striving. To some extent, this difference in 
trait coverage across scales is an asset to these analyses 
because a lack of significant differences in effects would 
suggest that estimated relationships are robust to choice 
of scale, while significant differences may point to 
more specific aspects of broad domains that are more 
strongly associated with outcomes (Hampson, 2012; 
Paunonen & Ashton, 2001). We provide a table of content 
measurement by scale online to highlight the difference 
in these measures.
Covariates
All analyses included age, education, and sex because 
of their known associations with personality traits 
and mortality risk. All Big Five traits were included in 
the models when available. Age for all studies was the 
participant age at the baseline assessment of personality 
and was standardized in each study. Gender was coded as 
1 (female) or 0 (male). Note, NAS was a male-only sample 
and as such did not adjust for gender. Education in EAS, 
HRS, ROS, OATS, LBLS, MAS, and MAP were measured as 
the number of total years of education. In MIDUS, NAS, and 
WLS, education was measured using an ordinal scale that 
referred to the highest degree earned. We standardized 
education within study.
Analytical Plan
Analytic decisions for this project were made prior to the 
analysis of any data by the first (NT), second (EG), and 
third (SW) authors of this manuscript. Development of the 
scripts used in R were also completed prior to analyses by 
the third author, using randomly seeded subsets of the HRS 
data. The HRS data was used as a template to develop code 
so the first three authors could evaluate if the R syntax ran 
successfully and provided the necessary output required 
to evaluate the study hypotheses. This R script created an 
output object containing meta-data, descriptive statistics, 
statistics from the inferential models and values predicted 
from the model. The “meta-analysis” scripts were written 
to extract relevant information from each of the output 
objects and evaluate the overall effect from the individual 
analyses. Analyses, including scripts, were pre-registered at 
this point. After pre-registration, the template scripts for 
the individual study analysis were sent to each study’s data 
analyst, who then completed the analysis. All scripts and 
data objects (not the data themselves, in order to comply 
with data sharing agreements) are available on OSF. We 
used R (Version 3.6.2; R Core Team, 2018) and the survival 
(Version 2.42-3; Therneau, 2019), ggplot2 (Version 3.0.0; 
Wickham et al., 2019), metafor (Version 2.0.0; Viechtbauer, 
2019), and sjPlot (Version 2.5.0; Lüdecke, 2020) packages 
for all of our analyses and visualizations. The survival 
package was used to estimate Cox regression models. 
Functions in the metafor package were used to estimate 
the overall effects and heterogeneity between studies, as 
well as to create the forest plots. The sjPlot package was 
used to calculate predicted values for each study and the 
ggplot2 package was used to visualize effects.
Individual Study Analysis
We estimated a series of Cox proportional hazards 
models (Cox, 1972) to examine whether neuroticism 
and conscientiousness interacted to significantly predict 
the hazard of dying in each study. Cox models take into 
Turiano et al: Healthy Neuroticism and MortalityArt. 33, page 8 of 16  
account the occurrence of a discrete outcome event 
(e.g., whether the person died or not over the specified 
follow-up) as well as the time interval of survival/death 
(e.g., how long did someone survive). For each predictor, 
a hazard ratio is estimated that indicates whether each 
standard deviation increase in that trait is associated with 
a reduced or increased hazard of death for the specified 
follow-up period. Based on our pre-registered study 
aims, we estimated three Cox models. First, we included 
baseline age, gender, education, and each of the Big Five 
personality traits as predictors of mortality. Second, we 
added the neuroticism by conscientiousness interaction 
to the model. Third, we included a three-way interaction 
(neuroticism by conscientiousness by gender), as well 
as the underlying two-way interactions to the model 
(neuroticism by gender; conscientiousness by gender).
We also fitted additional models to evaluate the 
robustness of effects. First, we tested an alternative 
time metric by using participants’ ages (i.e., age at the 
baseline personality assessment and age at death for 
when someone was censored because they survived) and 
ran the three identical models as described above. Second, 
we tested the proportionality assumption of our Cox 
models by interacting survival time with the neuroticism 
by conscientiousness interaction. A statistically significant 
interaction would suggest that the interaction effect 
of neuroticism and conscientiousness on mortality risk 
differed at certain times within each study. Results from 
these additional models can be found in the supplemental 
material. All analyses for the current project were pre-
registered and were conducted using R software.
Meta-Analysis
The analytic tools of meta-analysis were used to estimate 
the average weighted (by sample size) effect size for 
conscientiousness and neuroticism main effects, as well as 
for the interaction of neuroticism and conscientiousness 
predicting mortality risk. Using random effects meta-
analysis, this calculation included an estimation of 
heterogeneity in the effects between studies. The forest 
plots show the individual study effects, as well as the 
meta-analytic summaries.
Statistical Power
Given the anticipated sample size, we did not conduct a 
statistical power analysis with regards to our interaction 
coefficient estimate, or the coefficient estimates of 
neuroticism and conscientiousness at the time of pre-
registration. Moreover, our power to detect significant 
heterogeneity in effect sizes between studies is unclear. 
During the revision process of this manuscript we 
conducted a post-hoc power analysis using methods 
described by Hedges and Pigott (2004). Based on the 
within-study variability and the number of studies, we 
estimate that we are sufficiently able (power > .90) to 
detect heterogeneity of at least a standard deviation (in 
odds ratios) of .05 (corresponding τ of .08).
Results
Descriptive data for each study can be found here. 
Table 2 contains the main effects for trait neuroticism and 
conscientiousness (Model 1), as well as the neuroticism 
by conscientiousness interaction effects (Model 2). These 
models adjusted for age, gender, education, and the other 
Big Five personality traits. In Model 1, only 3 studies showed 
a significant association between higher neuroticism and 
greater hazard of dying over the corresponding study 
follow-up period (HRS, MIDUS, & ROS). None of the other 
studies showed significant associations for neuroticism 
(although the hazard ratios were in the same direction). 
The averaged association (weighted by N) was statistically 
significant (HR = 1.05; 95% CI = 1.02–1.07). There 
was not significant heterogeneity between the studies 
(Q(11) = 6.93, p = .805; I2 = 9.14). All but four studies 
(LBLS, NAS, OATS, & SLS) showed a significant protective 
effect of higher conscientiousness predicting a reduced 
Table 2: Proportional hazards models for each study.
Study Hazard Ratio (CI) Hazard Ratio (CI) Hazard Ratio (CI)
EAS 0.97 (0.78, 1.21) 0.75 (0.62, 0.91)** 1.11 (0.94, 1.32)
HRS 1.05 (1.01, 1.09)** 0.82 (0.79, 0.86)*** 0.98 (0.95, 1.01)
LBC 1.03 (0.88, 1.21) 0.82 (0.70, 0.95)** 0.99 (0.88, 1.10)
LBLS 1.08 (0.85, 1.37) 1.03 (0.82, 1.28) 0.99 (0.84, 1.17)
MAP 1.02 (0.88, 1.17) 0.85 (0.74, 0.99)* 1.11 (0.97, 1.27)
MAS 1.02 (0.85, 1.22) 0.75 (0.62, 0.89)** 1.03 (0.84, 1.27)
MIDUS 1.08 (1.01, 1.15)* 0.88 (0.82, 0.94)*** 0.99 (0.93, 1.04)
NAS 1.05 (0.96, 1.14) 1.01 (0.89, 1.13) 1.04 (0.95, 1.13)
OATS 1.02 (0.70, 1.49) 0.92 (0.68, 1.24) 1.24 (0.93, 1.66)
ROS 1.10 (1.02, 1.20)* 0.89 (0.82, 0.96)** 1.01 (0.95, 1.07)
SLS 1.07 (0.94, 1.22) 0.98 (0.86, 1.10) 0.95 (0.86, 1.04)
WLS 1.00 (0.94, 1.05) 0.93 (0.88, 0.98)** 0.98 (0.94, 1.02)
Note: * p < .05, ** p < .01, *** p < .001. Models adjusted for age, gender, education, and the other Big Five traits (when available).
Turiano et al: Healthy Neuroticism and Mortality Art. 33, page 9 of 16
hazard of dying with a significant overall meta-analytic 
effect for conscientiousness (HR = 0.88; 95% CI = 0.84–
0.93; Q(11) = 31.52, p = .001; I2 = 63.55).
None of the neuroticism by conscientiousness 
interactions were statically significant (Model 2). Figure 1 
contains the forest plot summarizing the individual study 
estimates for the neuroticism by conscientiousness 
interaction as well as the averaged effect (weighted by N) 
and meta-analytic statistics (I2) at the bottom of the plot. 
Lastly, none of the three-way interactions (neuroticism by 
conscientiousness by gender) were statistically significant, 
see link.
Supplementary Analyses
To further probe the data, we conducted additional analyses 
that were not a part of the initial preregistration process, 
but to address comments during the editorial process. First, 
we estimated additional models to determine if the main 
effects of conscientiousness or neuroticism changed when 
we did not adjust the models for the effects of the other 
personality traits (models were adjusted for age, gender, 
education, and either conscientiousness/neuroticism). 
The main effects for conscientiousness were very similar, 
but differences did emerge for neuroticism, see link. 
The main effects for neuroticism in HRS and MIDUS 
were still significant, but they were now protective. 
The averaged effect was also significant and protective. 
However, there were no studies that showed a significant 
conscientiousness by neuroticism interaction effect, nor 
an averaged interaction effect when not controlling for 
the other Big Five traits see link.
We also conducted additional analyses by using current 
age at baseline and attained age at death/censor date 
to ensure that our choice of time metric did not change 
the pattern of findings. Findings were not appreciably 
different if we used time or age as our time metric. We 
also tested the proportionality assumption by interacting 
time/age with the neuroticism by conscientiousness 
interaction. Two studies showed a slight violation of 
the proportionality assumption. In the MAS study, 
the neuroticism by conscientiousness interaction was 
significant within approximately the first 16 months of the 
study follow-up (among the youngest age groups in the 
study). Within WLS, the neuroticism by conscientiousness 
interaction was significant within approximately the first 
46 months of the study follow-up. These deviations were 
very minor and no consistent pattern emerged. The effect 
of the interaction was a risk-factor in the MAS whereas 
the interaction was protective within the WLS. Due to 
these minimal deviations and inconsistency in direction 
of effects, we remain hesitant to interpret these effects.
Discussion
The current project analyzed 12 different longitudinal 
studies to identify whether neuroticism and 
conscientiousness predicted mortality risk. The results 
are comparable to prior work suggesting that higher 
levels of conscientiousness are associated with decreased 
mortality risk. Significant associations between higher 
neuroticism and increased mortality risk were only found 
in three studies, while null effects were found in the 
others which is similar to an earlier investigation of many 
of the same studies (Graham et al., 2017). However, the 
main goal of this project was to test whether neuroticism 
and conscientiousness interact in their association 
with mortality. We hypothesized that higher levels of 
neuroticism would be associated with an increased 
mortality risk but only when levels of conscientiousness 
Figure 1: Forest Plot of Neuroticism by Conscientiousness Association with Mortality.
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were low. In other words, higher levels of conscientiousness 
would buffer the harmful effects of high neuroticism on 
mortality risk. Within each study, as well as in the pooled 
results, we found no statistical or descriptive evidence 
that such a trait interaction was associated with mortality 
risk. This lack of findings across the full set of studies is 
convincing since we had adequate power to find such 
associations if they existed.
The foundation of the current study was built on 
emerging evidence that the interaction of neuroticism by 
conscientiousness is associated with a host of behaviors 
and outcomes (Roberts, Smith, Jackson, & Edmonds, 2009; 
Turiano, Mroczek, Moynihan, & Chapman, 2013; Turiano 
et al., 2012; Vollrath & Torgersen, 2002). Since several 
investigations found that higher levels of neuroticism 
were associated with a reduced risk of dying (Korten et 
al., 1999; Weiss & Costa Jr., 2005), we borrowed from the 
healthy neuroticism concept to explain these somewhat 
counterintuitive findings. The large and diverse samples 
utilized, different personality assessments, long and short 
follow-up durations, and different age cohorts bolster 
our study design. Across the 12 studies, there was no 
clear evidence that higher levels of neuroticism had any 
protective effects. Only in our supplemental analyses 
requested by reviewers did we find that higher levels of 
neuroticism was associated with a reduced risk of death 
(MIDUS and HRS). However, this only occurred when we 
did not adjust for other personality traits (extraversion, 
agreeableness, and openness). We are hesitant to put 
much weight on these two individual findings because 
theoretical and conceptual frameworks suggest the Big 
Five are oblique factors and thus all five traits should 
be included in the same model. Regardless, we suggest 
several future directions to explore whether alternative 
operationalizations of healthy neuroticism may identify if 
neuroticism may have health-beneficial effects. We suggest 
several future directions to explore whether alternative 
operationalizations of healthy neuroticism may identify 
when neuroticism may have health-beneficial effects.
A strength of the current study is the large bandwidth of 
trait neuroticism and conscientiousness we covered with 
the different personality measures included in the analysis. 
The various measures adequately captured different 
aspects of neuroticism such as anxiousness/nervousness, 
depression, moodiness, and the responsibility, self-
disciplined aspects of conscientiousness. The IPIP-
50, IPIP, and Goldberg measures were very similar in 
adjective lists, while the BFI, BFI-S, and NEO measures had 
substantial overlap. Even with the diversity of personality 
measures, we still found a consistent pattern of null 
findings. Thus, we believe that the lack of neuroticism 
by conscientiousness interactions would generalize in 
studies using similar measures of the Big Five. However, 
we limited our analysis in the current paper to just the 
broad domains of neuroticism and conscientiousness. 
It is possible that only certain facets of neuroticism or 
conscientiousness drive healthy neuroticism. For example, 
high levels of underlying facets such as depressed affect 
or emotional reactivity are likely not conducive to health 
under any circumstances. However, higher levels on 
facets such as anxiety and self-consciousness could have 
protective effects on health if driven by proactive thinking 
(in this case, higher conscientiousness). Similarly, certain 
components of conscientiousness, such as being systematic 
and self-disciplined, may be more health-beneficial than 
others. Previous investigations have demonstrated that 
compared to analyses at the broad trait level, facet level 
analysis (Hampson, 2012; Paunonen & Ashton, 2001) 
or even item-level analysis (Mottus, Bates, Condon, 
Mroczek, & Revelle, 2017) can provide more leverage in 
the prediction of important life outcomes. For example, 
Gale and colleagues (2017) found that facets of worry and 
vulnerability were driving the effects of neuroticism in 
predicting a reduced risk of mortality. However, in Gale 
et al.’s study, these facets were derived from a bifactor 
model of neuroticism items and were uncorrelated with 
overall neuroticism, which was predictive of increased 
mortality hazards. Alternatively, others have found that 
greater impulsiveness was the facet driving the protective 
effect of high neuroticism being associated with increased 
longevity (Weiss & Costa Jr., 2005). The authors suggested 
that this puzzling finding may have something to do with 
biological resilience. We were limited in the current study 
and were unable to systematically analyze more specific 
facets and items due to the complexity of the different 
studies involved and different measures of personality. 
Each scale had different underlying facet structures or 
no set facet structure at all due to the brevity of some of 
the measures. Thus future research exploring facet-level 
interactions between neuroticism and conscientiousness 
should be one of the next steps to provide better insight 
into when higher levels of neuroticism may not be 
detrimental for health.
We also explored how findings may have differed by 
gender, but we did not find evidence of a significant 
three-way interaction involving gender, neuroticism, and 
conscientious. Since females typically score higher in 
neuroticism compared to males (Weisberg, DeYoung, & 
Hirsh, 2011), and prior work showing that neuroticism 
may not predict mortality risk similarly in females (e.g., 
Friedman et al., 2010b; Ploubidis & Grundy, 2009), we 
hypothesized that higher levels of conscientiousness 
would be more consequential for the higher levels of 
neuroticism in females. Thus, a stronger buffering effect 
could be evident and help to explain inconsistencies in 
prior work finding gender discrepancies in neuroticism-
mortality associations. Future work would benefit from 
exploring gender differences in personality-mortality 
associations, and gender differences in the personality-
health behavior associations. Relatedly, it could also be 
fruitful to examine non-linear effects of neuroticism. One 
prior study investigated non-linear effects of neuroticism 
and found a classic U-shaped association between anxiety 
and mortality risk (Mykletun et al., 2009). Mortality risk 
was increased when anxiety levels were within the lowest 
and highest quartiles but not in the two more average 
levels of anxiety. This finding parallels the Yerkes-Dodson 
model of arousal (Yerkes & Dodson, 1908) supporting the 
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notion that some anxiety may be health protective. Future 
work should attempt to determine the critical threshold 
level for neuroticism (or more specifically anxiety) to be 
“healthy” as well as whether that protective threshold 
depends on certain individual characteristics (i.e., gender, 
socioeconomic status) or at different stages of life span 
(i.e., emerging adulthood versus old age).
Revisiting Friedman’s (2000) initial idea of healthy 
neuroticism, we need to be clear that testing healthy 
neuroticism via a neuroticism by conscientiousness 
interaction was our group’s conceptualization of how to 
empirically identify healthy neuroticism. Since several 
studies have shown a buffering role of conscientiousness 
when neuroticism was high (e.g., Turiano et al., 2013, 2012), 
we thought a formal test of this interaction was the best 
approach to potentially explain discrepant findings of the 
neuroticism-mortality association. Future tests of healthy 
neuroticism may address alternative operationalizations 
such as neuroticism interactions with other positive 
individual difference constructs like perceived control 
beliefs (Infurna, Gerstorf, Ram, Schupp, & Wagner, 2011; 
Lachman & Firth, 2004), social support (Uchino, 2006), 
and purpose in life (McKnight & Kashdan, 2009). Socio-
demographic characteristics have also emerged as possible 
constructs to explore. Poorer self-rated physical health 
(Gale et al., 2017), higher socioeconomic status (Hagger-
Johnson et al., 2012), and better cognitive functioning 
(Weiss et al., 2009) interact with neuroticism such that 
the risk of higher neuroticism for death was attenuated. 
Although we did not test these alternative models in 
the current study, we plan to do so with future research 
and hope others with suitable data will also pursue 
such investigations. These psychosocial constructs are 
just a few examples of variables that could interact with 
neuroticism in a way that buffers the damaging effects of 
high neuroticism levels. We also must be clear that using 
the word “healthy” to describe neuroticism would only 
be accurate if higher levels of neuroticism had a positive 
impact on health, not just that the negative effects of 
higher neuroticism were absent when conscientiousness 
levels were high. Thus, caution should be used when 
describing the absence of a neuroticism effect versus a 
protective effect on health.
The current study focused solely on examining direct 
effects between personality and mortality, but future 
work would benefit from exploring indirect effects. Prior 
work shows that the neuroticism by conscientiousness 
interaction predicts health behaviors such as alcohol 
and tobacco use [Turiano et al. (2012); Graham et al., 
2020], such that highly neurotic individuals who are 
also conscientiousness do not engage in increased 
alcohol or tobacco use. Moreover, in this current issue 
we examined healthy neuroticism and health behaviors 
and found support across studies that higher levels of 
conscientiousness did in fact buffer the increased use 
of smoking and physical inactivity. Since alcohol and 
tobacco use and physical inactivity are among the leading 
behavioral contributors to earlier mortality (Mokdad, 
Marks, Stroup, & Gerberding, 2004), it would be logical to 
expect a person scoring higher in neuroticism who does 
not engage in such behaviors to have a health and/or 
longevity advantage. However, although so-called healthy 
neurotics engaged in slightly better health behaviors, 
this effect was likely not substantial enough to impact 
overall health in terms of the chronic stress or mortality 
outcomes we examined in the current study. It would 
be important for future work to empirically test indirect 
effects that would allow estimation of whether the health 
behaviors (e.g., alcohol or tobacco use, physical inactivity) 
would explain or mediate the association between 
the neuroticism by conscientiousness interaction and 
multiple health outcomes.
We also need to ensure that findings from the current 
study are weighed in careful consideration of study 
limitations. First, although we utilized a variety of 
longitudinal data sets from different countries, the sample 
is limited to those listed in the IALSA framework and 
include mostly studies of middle to older adults. However, 
this is also a strength of the current study because 
mortality rates are higher in later adulthood, thus giving 
us more power to detect associations with personality. We 
also did not explore cause-specific mortality in this analysis 
which could possibly shed light on potential deaths that 
may be more closely linked to healthy neuroticism (e.g., 
cardiovascular death). Lastly, it should be noted that since 
we used listwise deletion for missing data, the data is 
biased to those who had complete data. Moreover, since 
research has shown that personality is associated with 
drop-out, future studies should systematically test for 
selective attrition.
In closing, the current study included in this three-paper 
coordinated analysis investigated one operationalization 
of healthy neuroticism so conclusions generated about 
whether healthy neuroticism exists or not for mortality 
risk is limited to this single operationalization. We are 
confident in the null findings, due to adequacy of power 
we had to detect associations if they were there, as well 
as the remarkably homogeneous estimates from each 
study. Since the included studies are largely WEIRD 
samples(i.e., Westernized, Educated, Industrialized, Rich, 
and Democratic; Henrich, Heine, & Norenzayan, 2010), 
our results may not generalize to Eastern cultures or less-
industrialized countries, and to disadvantaged populations 
within the cultures studied here. Results are also limited to 
the specific mortality outcome we studied. We believe these 
results would generalize to measures of personality that 
were not used in the present study. There was little evidence 
that the present scales yielded different conclusions from 
each other, and we have no reason to believe these scales 
vary in a systematic way from other scales. We also believe 
that these results are likely to generalize over time, with 
the caveat being that improvements in society, specifically 
health care, may change the average life span and the 
incidence of disease and disability.
Conclusions
We sought to explain discrepancies regarding how 
neuroticism was associated with mortality risk. Specifically, 
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we attempted to find evidence of healthy neuroticism via 
a neuroticism by conscientiousness interaction. Although 
we did not find support for this operationalization of 
healthy neuroticism in predicting mortality risk, the 
current study was rigorous in terms of the methodological 
approach, the number and quality of the longitudinal 
data sets incorporated into our coordinated analysis, and 
the overall utility of predicting the ultimate objective 
health outcome – mortality. While this neuroticism by 
conscientiousness trait interaction does not appear to 
predict mortality risk, the idea of healthy neuroticism 
is appealing because it takes a well-established body 
of literature showing higher levels of neuroticism are 
associated with almost universal detrimental behaviors 
and outcomes (Lahey, 2009), and suggests this literature 
is incomplete because findings may not be as universal 
as once thought. We suggested several future directions 
to explore healthy neuroticism that can be used to 
identify under what conditions, for whom, and when 
in the lifespan higher levels of neuroticism may not 
be detrimental for health and may in fact be health- 
protective.
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